Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

324.71 +0.48 (+0.15%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
EC Selects Antibody Therapies, Arthritis Drug As Preferred COVID-19 Meds: Reuters
The European Commission (EC) picked four antibody treatments and a repurposed Eli Lilly And Co's (NYSE: LLY) rheumatoid arthritis drug for an initial... 
Via Benzinga
Exposures COVID-19
Eli Lilly To Look For Ways To Cut Insulin Costs After Walmart Debut: CNBC
Eli Lilly And Co (NYSE: LLY) CEO David Ricks said he welcomes new competition from Walmart Inc (NYSE: WMT) even as the retailer undercuts the company's insulin... 
Via Benzinga
Danaher Stock Rises To Fresh High; Alderon Acquisition Will Expand DNA Portfolio
Danaher stock rose June 18 after it said it's buying Aldevron, which makes DNA and mRNA, a component in Covid19 vaccines, for $9.6 billion. 
Via Investor's Business Daily
Precision Medicine Market Revenue to Cross USD 112 Bn by 2027: Global Market Insights Inc.
Major precision medicine market players include Eli Lilly & Company, bioMérieux, Laboratory Corporation Of America Holdings, Pfizer, Qiagen, Medtronic, Novartis, Quest Diagnostics, Abbott, Roche,... 
Via Newswire.com
Exposures COVID-19
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big... 
Via Benzinga
Exposures Product Safety
Stock Market Rally Revs To New Highs; Nike, Google, FedEx, Eli Lilly, Amazon In Focus: Weekly Review
The Nasdaq and S&P 500 hit highs as the stock market rally perked up, helped by a Biden infrastructure deal. Nike soared on earnings. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Oncology Drugs Market SWOT Analysis by Key Players- Amgen, Eli Lilly, AbbVie
Stay up-to-date with Oncology Drugs Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
45 Biggest Movers From Yesterday
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads... 
Via Benzinga
The Creeping Uptrend Continues with New Highs - Looking Beneath the Headlines
The Financial Sector caught a persistent bid today which boosted the small-cap Russell 2000 index and IWM. 
Via Talk Markets
Crazy Thursday
Today the US stock market went ballistic probably because of a higher joblessness level than expected. 
Via Talk Markets
These 2 Key Themes Are Driving the Stock Market to Record Highs
Find out what you need to know about all-time highs for stocks. 
Via The Motley Fool
Topics Economy Stocks
Exposures Economy US Equities
36 Stocks Moving In Thursday's Mid-Day Session
Gainers Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne... 
Via Benzinga
Lilly Stock Hits Record High On Key Alzheimer's Win, Looking To Follow Biogen
Eli Lilly's experimental Alzheimer's treatment snagged a key FDA designation on Thursday. LLY stock surged to a record high. 
Via Investor's Business Daily
Exposures Product Safety
Why Eli Lilly Stock Is Soaring Today
The company's promising Alzheimer's disease drug won FDA Breakthrough Therapy designation. 
Via The Motley Fool
Exposures Product Safety
Eli Lilly Jumps On Expedited Plans For Alzheimer's Drug, Biogen Falls
Eli Lilly announced that the Food and Drug Administration granted Breakthrough Therapy designation for donanemab, its investigational antibody therapy for Alzheimer's disease. 
Via Talk Markets
LLY Stock: The Alzheimer’s Drug News Sending Eli Lilly Higher Today
Eli Lilly (LLY) stock is soaring higher on Thursday following news of a decision from the FDA for its new Alzheimer's drug. 
Via InvestorPlace
Exposures Product Safety
PreMarket Prep Recap: The 4 Stocks Dennis Dick Bought Yesterday
On Wednesday’s PreMarket Prep, co-hosts Joel Elconin and Dennis Dick discussed the bullish chart setups in several tech stocks. ... 
Via Benzinga
Why Lilly Shares Are Moving Thursday
Eli Lilly and Company (NYSE: LLY) shares are advancing solidly Thursday following an update the company provided on its Alzheimer's program. What Happened: Lilly, which... 
Via Benzinga
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
BioCorRx Welcomes Four Experts to Expanded Scientific Advisory Board
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
Dual-Antibody Cocktail Shows Effectiveness In COVID-19 Animal Models: Reuters
In mice and hamster study, COVID-19 therapies comprising two types of antibodies were found to be effective against a wide range of COVID-19 variants, Reuters reported ... 
Via Benzinga
Exposures COVID-19
Roche's Alzheimer's Antibody Reduces Associated Biomarkers In Subset Of AD Patients, Study Shows
Experimental anti-amyloid antibodies from Eli Lilly & Co (NYSE: LLY) and Roche Holding AG's (OTC: RHHBY) failed to improve symptoms of Alzheimer's... 
Via Benzinga
How This Pharma Company Can Benefit From Its Competitors
Delays in FDA approval for Incyte could spell good news for Sanofi. 
Via The Motley Fool
Exposures Product Safety
Week In Review: This Week's China Life Science Deals Total Over $2.5 Billion
Shanghai's Zai Lab announced a four-drug immunonocology deal with MacroGenics ​​​worth over $1.4 billion. Shanghai's HutchMed (formerly Hutchison Chi-Med) is planning to raise $600 million in a Hong... 
Via Talk Markets
2 Stocks That Could Be Winners in Alzheimer's Disease Along With Biogen
One is Biogen's partner. The other is a potential rival. 
Via The Motley Fool
4 Top Stock Trades for Monday: MSFT, TWLO, LLY, GE
Microsoft, Twilio, Eli Lilly and General Electric were our top stock trades for Monday. Let's look at how the charts are setting up now. 
Via InvestorPlace
Biden Administration Devotes Over $3.2B For Development Of Oral Antiviral Therapies For COVID-19: CNBC
Officials on Thursday announced that the Biden Administration plans to invest more than $3.2 billion in developing antiviral medicines to treat COVID-19 and other... 
Via Benzinga
Exposures COVID-19
Market Briefing For Thursday, Jun. 17
Vulnerability is bifurcated, just like sector rotation indicated all year thus far. It is typical to see risk increased amidst superficial optimism at high S&P levels, but that's not really what moved... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Cramer Shares His Thoughts On Vertex Pharma, Snap And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said it's a good opportunity to pick up some Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX). The stock... 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.